Anti-thrombotic and Anticoagulant Treatment in Interventional Cardiology
Efforts to improve Percutaneous Transluminal Coronary Angioplasty (PTCA) have resulted in the usage of new antiplatelets, and antithrombotic agents. These new agents may increase bleeding complications. However, EPIC, EPILOG and CAPTURE trials showed benefits of 7E3, a GPIIb/IIIa platelets receptor...
Saved in:
Main Author: | Nithi Mahanonda |
---|---|
Other Authors: | Mahidol University |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/18591 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Direct oral anticoagulants in asian patients with atrial fibrillation: Consensus recommendations by the Asian Pacific Society of Cardiology on strategies for thrombotic and bleeding risk management
by: Daniel T.T. Chong, et al.
Published: (2022) -
Pragmatic recommendations for the management of anticoagulation and venous thrombotic disease for hospitalized patients with COVID-19 in low- And middle-income countries
by: Hanan Y. Ahmed, et al.
Published: (2022) -
Coronary Intervention 1996
by: Nithi Mahanonda, et al.
Published: (2018) -
Poor adherence to anticoagulation guidelines in patients with non-valvular atrial fibrillation treated in a tertiary cardiology unit
by: Kew, Guan Sen, et al.
Published: (2016) -
Thrombotic risk of children with thalassemia.
by: A. Chuansumrit, et al.
Published: (2018)